Role of Monoamine Oxidase A and Diet-Induced Monocyte Dysfunction, Macrophage Reprogramming, and Atherosclerosis

单胺氧化酶 A 与饮食引起的单核细胞功能障碍、巨噬细胞重编程和动脉粥样硬化的作用

基本信息

  • 批准号:
    10209393
  • 负责人:
  • 金额:
    $ 70.48万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-04-20 至 2026-03-31
  • 项目状态:
    未结题

项目摘要

Monocytes and macrophages are essential for tissue homeostasis, but in the context of metabolic disorders they become dysfunctional and promote chronic inflammatory diseases, including atherosclerosis. However, the underlying mechanisms are not well-understood. We showed that chronic exposure of blood monocytes to nutrient stress induced by a “Western”-style high-calorie diet (HCD) stimulates the formation of reactive oxygen species (ROS) and promotes protein thiol oxidation, resulting in monocyte dysfunction and the reprogramming of blood monocytes into a pro-inflammatory, pro-atherogenic phenotype, hyper-sensitive to chemoattractants. These metabolically “primed” blood monocytes give rise to reprogrammed and dysfunctional macrophages, sensitive to oxysterol-induced cell death, with defective autophagy and dysregulated activation profiles. Monocyte priming by nutrient stress is mediated by the H2O2-dependent S-glutathionylation, inactivation and degradation of mitogen-activated protein kinase phosphatase 1 (MKP-1), a master regulator of both monocyte adhesion and migration and macrophage function and plasticity. However, the source of HCD-induced H2O2 and “oxidative stress” in “primed” blood monocytes is not known. We have now identified monoamine oxidase A (Mao A) and NADPH oxidase 4 (Nox4) as novel sources of H2O2 induced by nutrient stress in monocytes and macrophages and as mediators of nutrient stress-induced monocyte priming and dysfunction. We hypothesize that the induction of Mao A in monocytes in response to a HCD accelerates atherogenesis by promoting H2O2 production and the inactivation of MKP-1, resulting in monocyte priming and reprogramming, and giving rise to dysfunctional, hyper-inflammatory and pro-atherogenic monocyte-derived macrophages with impaired inflammation resolving capabilities. Furthermore, we propose that by inactivating the thiol transferase glutaredoxin 1 (Grx1) and disrupting thiol redox homeostasis, Mao A-derived H2O2 promotes the induction of Nox4, amplifying the oxidative stress response triggered by HCD. To test these hypotheses and to elucidate the underlying mechanisms, we propose the following Specific Aims: Specific Aim 1: Determine the mechanisms by which high-calorie diet-triggered induction of Mao A promotes monocyte dysfunction, dysregulates macrophage plasticity, and accelerates atherogenesis. Specific Aim 2: Determine the contribution of Nox4 to high-calorie diet-induced monocyte priming, macrophage dysfunction, and atherogenesis. Specific Aim 3: Determine the molecular mechanisms by which high-calorie diets trigger monocyte priming and reprogramming in metabolically healthy human subjects and whether and to what extent these mechanisms differ from mice.
单核细胞和巨噬细胞对于组织稳态是必不可少的,但在代谢紊乱的情况下, 变得功能失调并促进慢性炎症性疾病,包括动脉粥样硬化。但 根本的机制还不清楚。我们发现血液单核细胞长期暴露于 由“西方”式高热量饮食(HCD)引起的营养应激刺激活性氧的形成 活性氧(ROS)和促进蛋白巯基氧化,导致单核细胞功能障碍和重编程 将血液单核细胞转化为促炎、促动脉粥样硬化的表型,对化学引诱物高度敏感。 这些代谢“启动”的血液单核细胞产生重编程和功能障碍的巨噬细胞, 对氧固醇诱导的细胞死亡敏感,具有缺陷的自噬和失调的激活特征。 营养应激引起的单核细胞启动是由H2 O2依赖的S-谷胱甘肽化、失活和 有丝分裂原活化蛋白激酶磷酸酶1(MKP-1)的降解,MKP-1是单核细胞 粘附和迁移以及巨噬细胞功能和可塑性。然而,HCD诱导的H2 O2和 “致敏的”血液单核细胞中的“氧化应激”是未知的。我们现在已经鉴定出单胺氧化酶A(Mao A)和NADPH氧化酶4(Nox 4)作为单核细胞中营养应激诱导的H2 O2的新来源, 巨噬细胞和作为介质的营养应激诱导的单核细胞启动和功能障碍。我们假设 单核细胞中Mao A的诱导对HCD的反应通过促进动脉粥样硬化的发生而加速动脉粥样硬化的发生。 H2 O2产生和MKP-1失活,导致单核细胞启动和重编程,以及 引起功能障碍、高度炎症和促动脉粥样硬化的单核细胞衍生的巨噬细胞 炎症消退能力受损此外,我们建议通过使硫醇失活, 转移酶谷氧还蛋白1(Grx 1)和破坏巯基氧化还原稳态,Mao A衍生的H2 O2促进了 诱导Nox 4,放大HCD引发的氧化应激反应。为了验证这些假设, 阐明潜在的机制,我们提出以下具体目标: 具体目标1:确定高热量饮食触发诱导Mao A的机制 促进单核细胞功能障碍、巨噬细胞可塑性失调和加速动脉粥样硬化形成。 具体目标2:确定Nox 4对高热量饮食诱导的单核细胞启动的贡献, 巨噬细胞功能障碍和动脉粥样硬化形成。 具体目标3:确定高热量饮食触发单核细胞的分子机制 在代谢健康的人类受试者中的启动和重编程,以及是否以及在多大程度上 这些机制不同于小鼠。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Reto H.R. Asmis其他文献

Reto H.R. Asmis的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Reto H.R. Asmis', 18)}}的其他基金

Role of Monoamine Oxidase A and Diet-Induced Monocyte Dysfunction, Macrophage Reprogramming, and Atherosclerosis
单胺氧化酶 A 与饮食引起的单核细胞功能障碍、巨噬细胞重编程和动脉粥样硬化的作用
  • 批准号:
    10395540
  • 财政年份:
    2021
  • 资助金额:
    $ 70.48万
  • 项目类别:
Role of Monoamine Oxidase A and Diet-Induced Monocyte Dysfunction, Macrophage Reprogramming, and Atherosclerosis
单胺氧化酶 A 与饮食引起的单核细胞功能障碍、巨噬细胞重编程和动脉粥样硬化的作用
  • 批准号:
    10614941
  • 财政年份:
    2021
  • 资助金额:
    $ 70.48万
  • 项目类别:
Atheroprotective Mechanisms of Ursolic Acid and Related Phytochemicals
熊果酸和相关植物化学物质的动脉粥样硬化保护机制
  • 批准号:
    8601171
  • 财政年份:
    2013
  • 资助金额:
    $ 70.48万
  • 项目类别:
Atheroprotective Mechanisms of Ursolic Acid and Related Phytochemicals
熊果酸和相关植物化学物质的动脉粥样硬化保护机制
  • 批准号:
    9207749
  • 财政年份:
    2013
  • 资助金额:
    $ 70.48万
  • 项目类别:
Atheroprotective Mechanisms of Ursolic Acid and Related Phytochemicals
熊果酸和相关植物化学物质的动脉粥样硬化保护机制
  • 批准号:
    8790952
  • 财政年份:
    2013
  • 资助金额:
    $ 70.48万
  • 项目类别:
Atheroprotective Mechanisms of Ursolic Acid and Related Phytochemicals
熊果酸和相关植物化学物质的动脉粥样硬化保护机制
  • 批准号:
    9588860
  • 财政年份:
    2013
  • 资助金额:
    $ 70.48万
  • 项目类别:
Atheroprotective Mechanisms of Ursolic Acid and Related Phytochemicals
熊果酸和相关植物化学物质的动脉粥样硬化保护机制
  • 批准号:
    8992356
  • 财政年份:
    2013
  • 资助金额:
    $ 70.48万
  • 项目类别:
Atheroprotective Mechanisms of Ursolic Acid and Related Phytochemicals
熊果酸和相关植物化学物质的动脉粥样硬化保护机制
  • 批准号:
    8444366
  • 财政年份:
    2013
  • 资助金额:
    $ 70.48万
  • 项目类别:
Nox4 and the Redox-Regulation of MKPs in Monocyte Recruitment and Atherosclerosis
Nox4 和 MKP 在单核细胞募集和动脉粥样硬化中的氧化还原调节
  • 批准号:
    8901570
  • 财政年份:
    2012
  • 资助金额:
    $ 70.48万
  • 项目类别:
Nox4 and the Redox-Regulation of MKPs in Monocyte Recruitment and Atherosclerosis
Nox4 和 MKP 在单核细胞募集和动脉粥样硬化中的氧化还原调节
  • 批准号:
    8394001
  • 财政年份:
    2012
  • 资助金额:
    $ 70.48万
  • 项目类别:

相似海外基金

Targeted ablation of cerebral atherosclerosis using supramolecular self-assembly
利用超分子自组装靶向消融脑动脉粥样硬化
  • 批准号:
    24K21101
  • 财政年份:
    2024
  • 资助金额:
    $ 70.48万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Body composition and atherosclerosis-related biomarkers in women with endometriosis
子宫内膜异位症女性的身体成分和动脉粥样硬化相关生物标志物
  • 批准号:
    23K15842
  • 财政年份:
    2023
  • 资助金额:
    $ 70.48万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Targeted multimodal stimuli-responsive nanogels for atherosclerosis imaging and therapy
用于动脉粥样硬化成像和治疗的靶向多模式刺激响应纳米凝胶
  • 批准号:
    2880683
  • 财政年份:
    2023
  • 资助金额:
    $ 70.48万
  • 项目类别:
    Studentship
The Epigenetic Regulator Prdm16 Controls Smooth Muscle Phenotypic Modulation and Atherosclerosis Risk
表观遗传调节因子 Prdm16 控制平滑肌表型调节和动脉粥样硬化风险
  • 批准号:
    10537602
  • 财政年份:
    2023
  • 资助金额:
    $ 70.48万
  • 项目类别:
Role of IL-6 trans signaling in atherosclerosis development and late-stage pathogenesis
IL-6反式信号传导在动脉粥样硬化发展和晚期发病机制中的作用
  • 批准号:
    10652788
  • 财政年份:
    2023
  • 资助金额:
    $ 70.48万
  • 项目类别:
Novel Mechanisms Underlying the Development of Atherosclerosis
动脉粥样硬化发展的新机制
  • 批准号:
    10589484
  • 财政年份:
    2023
  • 资助金额:
    $ 70.48万
  • 项目类别:
Alcohol Regulation of Endothelial Plasticity in Atherosclerosis
酒精对动脉粥样硬化内皮可塑性的调节
  • 批准号:
    10585070
  • 财政年份:
    2023
  • 资助金额:
    $ 70.48万
  • 项目类别:
From genotype to phenotype in a GWAS locus: the role of REST in atherosclerosis
GWAS 位点从基因型到表型:REST 在动脉粥样硬化中的作用
  • 批准号:
    10570469
  • 财政年份:
    2023
  • 资助金额:
    $ 70.48万
  • 项目类别:
2023 Atherosclerosis
2023 动脉粥样硬化
  • 批准号:
    10675221
  • 财政年份:
    2023
  • 资助金额:
    $ 70.48万
  • 项目类别:
The role of extracellular vesicle-associated MicroRNAs in HIV-associated atherosclerosis
细胞外囊泡相关 MicroRNA 在 HIV 相关动脉粥样硬化中的作用
  • 批准号:
    10619831
  • 财政年份:
    2023
  • 资助金额:
    $ 70.48万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了